More effort needed on real-world medical data, say EU regulators

Use of medical data from outside clinical trials can bolster decision-making, says European Medicines Agency

More effort is needed to develop ways to incorporate real-world data into medical decision-making, according to the EU’s healthcare regulators.

On 23 June, the European Medicines Agency (EMA) and European Medicines Regulatory Network published a report on their experiences so far of using data from outside controlled clinical environments to help evaluate the performance and safety of medical treatments.